Weiyan Zhou

Prof. Dr. Weiyan Zhou


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2021 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
ZLZhenni Liu
Zhenni Liu
QLQingxiang Liu
Qingxiang Liu
YDYuhang Deng
Yuhang Deng
HZHaijian Zhao
Haijian Zhao
JZJie Zeng
Jie Zeng
CZChuanbao Zhang
Chuanbao Zhang

24 February 2023 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
YDYuhang Deng
Yuhang Deng
CZChao Zhang
Chao Zhang
JWJing Wang
Jing Wang
JZJie Zeng
Jie Zeng
JZJiangtao Zhang
Jiangtao Zhang
CZChuanbao Zhang
Chuanbao Zhang
Yuhang Deng, M.D., Chao Zhang, M.D., Jing Wang, M.M., Jie Zeng, M.M., Jiangtao Zhang, M.M., Tianjiao Zhang, M.D., Haijian Zhao, M.M., Weiyan Zhou, M.D., and Chuanbao Zhang, M.D.. Ann Lab Med 2023;43:345-54. https://doi.org/10.3343/alm.2023.43.4.345

1 July 2022 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
WZWeiyan Zhou
Weiyan Zhou
M.M.D.
M.D.
YDYuhang Deng
Yuhang Deng
HZHaijian Zhao
Haijian Zhao
CZChuanbao Zhang
Chuanbao Zhang
Weiyan Zhou , M.D., Yuhang Deng , M.D., Haijian Zhao , M.D., and Chuanbao Zhang , M.D.. Ann Lab Med 2022;42:428-37. https://doi.org/10.3343/alm.2022.42.4.428

21 March 2022 in Clinical Biochemistry
Verified
Journal Article
Closed access
WZWeiyan Zhou
Weiyan Zhou
YDYuhang Deng
Yuhang Deng
CZChao Zhang
Chao Zhang
ZLZhenni Liu
Zhenni Liu
JZJiangtao Zhang
Jiangtao Zhang
CZChuanbao Zhang
Chuanbao Zhang

25 October 2022 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
ZLZhenni Liu
Zhenni Liu
LJLizi Jin
Lizi Jin
WZWeiyan Zhou
Weiyan Zhou
CZChuanbao Zhang
Chuanbao Zhang
Background: Plasma renin activity (PRA) is one of the recommended screening indicators for primary aldosteronism (PA) diagnosis and had become increasingly important in hypertension identification, medication guidance, and endocrine disorder confirmation.Methods: To provide an overview of the PRA measurement progress and clinical value, this review summarizes the main contributing factors related to PRA measurement and necessary precautions during the entire analysis process. We also outline the characteristics of PRA in different endocrine diseases and their clinical utility.Results: Significant inconsistency was observed in PRA measurement methods, including immunoassay and isotope dilution liquid chromatography–tandem mass spectrometry (ID‐LC/MS/MS), which could be attributed to preanalytical, analytical, and postanalytical variations. Meanwhile, consensus about environmental and procedural factors during the entire analytical process, including storage temperature, incubation condition, blank subtraction, and standardized operational procedures across different self‐developed assay laboratories, could be important to minimize analytical variations. Furthermore, commutable uniform calibrators should be prepared to improve consistency, ultimately achieving accurate and reliable measurement of PRA.Conclusion: This review summarizes the clinical utilization of PRA as a biomarker in multiple diseases, elaborating on routine detection methods and the key factors in the analytical process. We also provide feasible strategies for improving standardization and facilitating PRA assessment for larger‐scale clinical applications.

4 September 2023 in Clinica Chimica Acta
Verified
Journal Article
Closed access
ZLZhenni Liu
Zhenni Liu
LJLizi Jin
Lizi Jin
ZMZijia Ma
Zijia Ma
XNXiaerbanu Nizhamuding
Xiaerbanu Nizhamuding
JZJie Zeng
Jie Zeng
CZChuanbao Zhang
Chuanbao Zhang